Suchergebnisse - "Du, Weijiao"

PubPharm (13)

1

The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma

enthalten in: The Journal of pathology | 2024

von Zeng, Z. | Du, W. | Yang, F. | +7

2

Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I-IIIA LUAD

enthalten in: Journal of leukocyte biology | 2024

von Du, W. | Yang, F. | Hui, Z. | +4

3

Vemurafenib for BRAF V600-mutant Erdheim-Chester disease presenting with bilateral orbital involvement

enthalten in: Clinical case reports | 2023

von Wang, X. | Cao, J. | Du, W. | +3

4

Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement

enthalten in: Clinical Case Reports | 2023

von Wang, X. | Cao, J. | Du, W. | +3

5

A Phase IB Trial of Autologous Cytokine-Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death-1, plus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2022

von Zhou, L. | Xiong, Y. | Wang, Y. | +24

6

Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy : a case report

enthalten in: Gland surgery | 2022

von Li, S. | Zhang, J. | Du, W. | +2

7

Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events

enthalten in: Cancer biology & medicine | 2021

von Zhang, W. | Meng, Y. | Yang, L. | +10

8

Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification

enthalten in: Clinical case reports | 2021

von Wang, X. | Cao, J. | Du, W. | +2

9

Autologous cytokine-induced killer (CIK) cells enhance the clinical response to PD-1 blocking antibodies in patients with advanced non-small cell lung cancer : A preliminary study

enthalten in: Thoracic cancer | 2021

von Han, Y. | Mu, D. | Liu, T. | +8

10

Autologous cytokine‐induced killer ( CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer : A preliminary study

enthalten in: Thoracic Cancer | 2021

von Han, Y. | Mu, D. | Liu, T. | +8